Business Wire

The Smarter E Europe: Launch of Special Exhibit on Bidirectional Charging – the Energy Transition Gains Traction

Share

Electricity from renewable sources has become the new normal – in Germany alone, around 60 percent of net electricity generation came from renewables in 2024. But the growing volume of green power is posing new challenges for energy supply: The integration into the existing system urgently requires more flexibility. A Euroelectric/EY study forecasts a doubling of daily European flexibility demand by 2030 compared to 2021, potentially reaching 1.8 TWh daily (137 TWh annually), a substantial rise from the prior 1.5 TWh weekly demand. Electric vehicle (EV) batteries are identified as a key flexibility solution, potentially offering around 116 TWh capacity within five years.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250417476684/en/

A special exhibition at The smarter E Europe is dedicated to bidirectional charging. ©Solar Promotion GmbH

Dr. Frank Spennemann, Senior Manager Charging Solutions Energy at Mercedes-Benz, has a clear view of the importance of bidirectional charging, particularly vehicle-to-grid technology, for the success of the energy transition: “Research simulations have shown that bidirectional vehicles are key for grid stability and the transition to renewable sources of energy.” In France, a collaboration between Renault, a car manufacturer, and The Mobility House has launched a scheme enabling electricity customers to make their vehicle batteries available as grid-serving electricity storage systems in exchange for free charging. Marcus Fendt, Managing Director of The Mobility House, explains: “EV batteries are the most convenient storage option because the average car parking time is 23 hours per day. The average daily distance travelled by car in Germany is 36 kilometers. This corresponds to an energy consumption of around 8 kWh, or even less for very efficient e-cars.”

Today’s technology for tomorrow’s world

At the special exhibit on bidirectional charging, visitors will have the opportunity to learn about available components and solutions, to get a glimpse of the future and to talk to leading industry players. The special exhibit can be found in hall C6, right next to the Power2Drive Forum, on all three exhibition days. Exhibits and live demos will show how vehicle-to-X technology works in practice, be it vehicle-to-grid, vehicle-to-building, vehicle-to-load or vehicle-to-home. Through lectures and discussions, attendees will be able to get first-hand expert information on how bidirectional charging will change our energy system and which developments will shape its future. The special exhibit will also showcase inspiring projects and practical examples from Germany, Europe and across the world.

Forums and guided tours

One of the hot topics at The smarter E Europe exhibition forums will be bidirectional charging: Various aspects of vehicle-to-X technologies will be examined in seven sessions with high-carat speakers; five of these sessions will be part of the Power2Drive Forum. On all three exhibition days, the organizers will be offering guided tours during which industry experts will provide. The guided tours start from the info counter at the special exhibit on bidirectional charging at 11:30am and 3:30pm on all three days.

Special exhibit with strong support

The collaborative partners of the special exhibit on bidirectional charging contribute technical expertise and a wide range and in-depth insights. The organizers are delighted about the collaboration with E-Mobility Europe and Eurelectric, the European industry associations, the Research Center for Energy Economics (FfE), Lade GmbH, the National Center for Charging Infrastructure, Smart Energy Europe and The Mobility House. Sigenergy and Bi-CCS are sponsoring the event.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250417476684/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Antibody Solutions Launches Single Plasma B-Cell Services through Cellestive Discovery Platform22.4.2025 13:00:00 CEST | Press release

New, exclusive capability will allow antibody discovery clients to access more hits and more screening data than competing technologies Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s exclusive Cellestive antibody discovery platform. The new capability completes a trifecta of B-cell services offered through Cellestive, which already includes discovery pathways for both activated and memory B-cells. The new plasma B-cell service is projected to be of particular value to clients pursuing difficult targets in antibody discovery, enabling them to leverage new processes and technologies while accessing broader, deeper data to inform their decision-making. “This really rounds out our Cellestive platform and allows us to robustly and efficiently interrogate single plasma B-cells for our clients,” said John Kenney, Phd, co-founder and president o

Sun Nuclear Announces Completion of Transition to CE Class IIb EU MDR Certification for Key Quality Management Solutions22.4.2025 12:04:00 CEST | Press release

SunCHECK® Software, SRS MapCHECK® and SunSCAN™ 3D DevicesAmong 15+ Solutions Awarded New Certification Sun Nuclear, a Mirion Medical company, announced today that its SunCHECK® Quality Management software and key radiation therapy Quality Assurance (QA) devices have been awarded CE Class IIb certification under the European Medical Devices Regulation 2017/745 (EU MDR). The transition to EU MDR Class IIb recognizes the safety and performance of Sun Nuclear solutions and confirms compliance with stringent safety requirements. Sun Nuclear solutions awarded Class IIb certification include: The SunCHECK® Platform, a comprehensive software application facilitating essential Patient and Machine QA workflows and centralized data management; Patient-specific QA solutions, including the ArcCHECK®, ArcCHECK®-MR, MapCHECK® 3 and SRS MapCHECK® devices, for measurement of radiation dose distributions against planned doses; Machine QA solutions, including the Daily QA™ 3, Daily QA™ 3-MR, IC PROFILER™

Regula Becomes the First to Verify All Dynamic Security Features in Remote Document Checks22.4.2025 12:00:00 CEST | Press release

With the recent update of its Document Reader SDK, Regula became the first identity verification (IDV) vendor to make it possible to verify all the dynamic security features of documents in real time. With the latest addition of Dynaprint® checks, the solution ensures more robust physical document authentication during remote onboarding. The innovation has arrived at a time when 58% of businesses globally face fake or modified IDs during digital onboarding. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422724077/en/ Dynaprint in the Arizona’s driver’s license (Photo: Regula) Dynaprint® is a dynamic security feature consisting of two different images printed with lenticular technology. Depending on the angle of observation, only one image is visible at a time. Like all other dynamic security features, Dynaprint is crucial for securing identity documents from tampering, since it’s a tricky task to fake it without special e

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression22.4.2025 12:00:00 CEST | Press release

Highlights: Participants received a single dose of either 25 mg of COMP360 or placebo On track for disclosure of top-line 6-week primary endpoint results in late June Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that all participants have completed dosing in Part A of the COMP005 phase 3 trial for treatment resistant depression (TRD). Following pre-dosing activities, including washout from anti-depressant medications, if needed, participants received a single dose of either 25 mg of COMP360 or placebo. The Company is on track to disclose top-line 6-week primary endpoint results in late June. “Completing dosing of all participants in Part A of our 005 trial marks a critical milestone in our mission to address the pressing unmet need in treatment resistant depression,” said Kabir Nath, CEO Compass Pathways. “We are proud of this achievement which reflects our team’s commitment to scient

Egle Therapeutics to Highlight Novel Preclinical Findings for Regulatory T Cells Targeting Programs EGL-001 and EGL-002 With Poster Presentations at the 2025 AACR Annual Meeting22.4.2025 10:37:00 CEST | Press release

Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, will present two posters at the American Association for Cancer Research Annual Meeting (AACR) 2025 being held in Chicago April 25-30, 2025. In the poster, entitled “Preferential tumor uptake and retention of EGL-001, an anti-CTLA4-IL2 mutein fusion antibody achieving selective tumor Treg depletion”. Egle Therapeutics unveils preclinical biodistribution data on EGL-001, a novel anti-CTLA4-IL2 mutein fusion antibody designed to selectively deplete tumor-infiltrating regulatory T cells (Tregs). EGL-001 mode of action combines competitive inhibition of IL-2 signaling and potent downregulation of surface CD25, leading to induction of Treg apoptosis. In vivo EGL-001 preferentially bound to the surface of Tregs due to their high CTLA-4 and CD25 expression and depleted them from the tumor microenvironment without affecting other immun

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye